Cristin L. Rothfuss - 04 Mar 2025 Form 4 Insider Report for Sarepta Therapeutics, Inc. (SRPT)

Role
EVP, General Counsel
Signature
/s/ Cristin Rothfuss
Issuer symbol
SRPT
Transactions as of
04 Mar 2025
Net transactions value
-$59,183
Form type
4
Filing time
06 Mar 2025, 20:00:09 UTC
Previous filing
04 Mar 2025
Next filing
10 Mar 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SRPT Common Stock Tax liability $29,186 -288 -2.2% $101.34 13,037 04 Mar 2025 Direct F1
transaction SRPT Common Stock Tax liability $29,997 -296 -2.2% $101.34 13,325 04 Mar 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were sold by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 3, 2021.